azd4694
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT00838877)
Timeline
Indications
Mechanism of action
- Amyloid beta A4 proteinRadiopharmaceutical
APP radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- azd4694
- azd4694
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01325402 | Phase 1 | Aug 31, 2011 | AstraZeneca |
| NCT00991419 | Phase 2 | Feb 1, 2010 | AstraZeneca, University of Arizona |
| NCT00838877 | Phase 1 | Jan 1, 2009 | AstraZeneca, Karolinska Institute |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 3 | 3 | 2 | 2009 |
| Karolinska Institute | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Arizona | Academic/Hospital | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1